Global T-Cell & NK-Cell Engaging Bispecific Antibodies Competitive Landscape Professional Research Report 2024

Research Summary

T-cell and NK-cell engaging bispecific antibodies are a type of therapeutic antibody designed to harness the immune system's natural ability to target and kill cancer cells. These antibodies are engineered to simultaneously bind to both cancer cells and either T-cells (T lymphocytes) or NK cells (natural killer cells), two types of immune cells that play key roles in immune surveillance and tumor elimination. By bridging the interaction between immune cells and cancer cells, T-cell and NK-cell engaging bispecific antibodies redirect the immune response towards cancer cells, leading to their destruction. This dual targeting mechanism enhances the specificity and potency of the immune response against tumors, potentially overcoming immune evasion mechanisms employed by cancer cells. T-cell and NK-cell engaging bispecific antibodies have shown promising results in preclinical and clinical studies for the treatment of various cancers, including hematologic malignancies and solid tumors. They represent an innovative approach to cancer immunotherapy and hold potential for improving outcomes in patients with cancer.

According to DIResearch's in-depth investigation and research, the global T-Cell & NK-Cell Engaging Bispecific Antibodies market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of T-Cell & NK-Cell Engaging Bispecific Antibodies include Amgen, Immunocore, Johnson & Johnson, Roche, Pfizer, AbbVie, MacroGenics, Regeneron etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of T-Cell & NK-Cell Engaging Bispecific Antibodies. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global T-Cell & NK-Cell Engaging Bispecific Antibodies market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the T-Cell & NK-Cell Engaging Bispecific Antibodies market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of T-Cell & NK-Cell Engaging Bispecific Antibodies industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of T-Cell & NK-Cell Engaging Bispecific Antibodies Include:

Amgen

Immunocore

Johnson & Johnson

Roche

Pfizer

AbbVie

MacroGenics

Regeneron

T-Cell & NK-Cell Engaging Bispecific Antibodies Product Segment Include:

T-Cell Engagers

NK-Cell Engagers

T-Cell & NK-Cell Engaging Bispecific Antibodies Product Application Include:

Hematological Cancers

Solid Tumors

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global T-Cell & NK-Cell Engaging Bispecific Antibodies Industry PESTEL Analysis

Chapter 3: Global T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Porter's Five Forces Analysis

Chapter 4: Global T-Cell & NK-Cell Engaging Bispecific Antibodies Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size and Forecast by Type and Application Analysis

Chapter 6: North America T-Cell & NK-Cell Engaging Bispecific Antibodies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China T-Cell & NK-Cell Engaging Bispecific Antibodies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) T-Cell & NK-Cell Engaging Bispecific Antibodies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global T-Cell & NK-Cell Engaging Bispecific Antibodies Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Overview

1.1 Product Definition and Statistical Scope

1.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Product by Type

1.2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 T-Cell Engagers

1.2.3 NK-Cell Engagers

1.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Product by Application

1.3.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Hematological Cancers

1.3.3 Solid Tumors

1.4 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Revenue and Sales Analysis

1.4.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size Analysis (2019-2030)

1.4.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Sales Analysis (2019-2030)

1.4.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Sales Price Trend Analysis (2019-2030)

1.5 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Development Status and Trends

1.5.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Development Status Analysis

1.5.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Development Trends Analysis

2 T-Cell & NK-Cell Engaging Bispecific Antibodies Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Analysis by Regions

4.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Overall Market: 2023 VS 2024 VS 2030

4.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue and Forecast Analysis (2019-2030)

4.2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue and Market Share by Region (2019-2024)

4.2.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Forecast by Region (2025-2030)

4.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Forecast Analysis (2019-2030)

4.3.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Market Share by Region (2019-2024)

4.3.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Forecast by Region (2025-2030)

4.4 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Price Trend Analysis (2019-2030)

5 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Type and Application

5.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Type

5.1.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue and Forecast Analysis by Type (2019-2030)

5.1.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Forecast Analysis by Type (2019-2030)

5.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Application

5.2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue and Forecast Analysis by Application (2019-2030)

5.2.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Forecast Analysis by Application (2019-2030)

6 North America

6.1 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Type

6.3.1 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2019-2030)

6.3.2 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2019-2030)

6.4 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Application

6.4.1 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2019-2030)

6.4.2 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2019-2030)

6.5 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Type

7.3.1 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2019-2030)

7.3.2 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2019-2030)

7.4 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Application

7.4.1 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2019-2030)

7.4.2 ? Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2019-2030)

7.5 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Type

8.3.1 China T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2019-2030)

8.3.2 China T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2019-2030)

8.4 China T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Application

8.4.1 China T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2019-2030)

8.4.2 China T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2019-2030)

9 APAC (excl. China)

9.1 APAC (excl. China) T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Type

9.3.1 APAC (excl. China) T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2019-2030)

9.3.2 APAC (excl. China) T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2019-2030)

9.4 APAC (excl. China) T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Application

9.4.1 APAC (excl. China) T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2019-2030)

9.4.2 APAC (excl. China) T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2019-2030)

9.5 APAC (excl. China) T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Type

10.3.1 Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2019-2030)

10.3.2 Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2019-2030)

10.4 Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Application

10.4.1 Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2019-2030)

10.4.2 Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2019-2030)

10.5 Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country

10.5.1 Mexico

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Type

11.3.1 Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2019-2030)

11.3.2 Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2019-2030)

11.4 Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Application

11.4.1 Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2019-2030)

11.4.2 Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2019-2030)

11.5 Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Competition by Manufacturers

12.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Sales, Revenue and Price by Key Manufacturers (2020-2024)

12.1.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Sales by Key Manufacturers (2020-2024)

12.1.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Revenue by Key Manufacturers (2020-2024)

12.1.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Average Sales Price by Manufacturers (2020-2024)

12.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Competitive Landscape Analysis and Market Dynamic

12.2.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Amgen

13.1.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio

13.1.3 Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.2 Immunocore

13.2.1 Immunocore Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio

13.2.3 Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.3 Johnson & Johnson

13.3.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio

13.3.3 Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.4 Roche

13.4.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio

13.4.3 Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.5 Pfizer

13.5.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio

13.5.3 Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.6 AbbVie

13.6.1 AbbVie Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio

13.6.3 AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.7 MacroGenics

13.7.1 MacroGenics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio

13.7.3 MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.8 Regeneron

13.8.1 Regeneron Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio

13.8.3 Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Chain Analysis

14.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Upstream Supply Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Typical Downstream Customers

14.4 T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support